Comparison of Topical Corticosteroid (0.05% Clobetasol Propionate) Treatment and 1% Pimecrolimus Treatment in Alopecia Areata Patients

    January 2009
    Haydar Uçak
    Studysummary In this study, 1% pimekrolimus cream was found to be more effective than 0.05% clobetasol propionate for treating active plaques in patients with alopecia areata.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on hdl.handle.net →
    Discuss this study in the Community →

    Related research 3

    1. Comparative Evaluation of Efficacy Between Topical Calcipotriol Used Along With Topical Clobetasol and Topical Clobetasol Monotherapy in Treatment of Alopecia Areata: A Randomized Clinical Trial Journal of clinical and diagnostic research · 2021
    2. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Dermatology and therapy · 2020
    3. Comparison of Treatment with Clobetasol Propionate 0.05% and Topical Pimecrolimus 1% in Alopecia Areata Journal of Dermatological Treatment · 2011